Alveolar type II cells inhibit fibroblast proliferation: Role of IL-1α

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 290, Issue 2, 2006, Pages

  Portnoy, Joshua ^a,c   Pan, Tianli ^a   Dinarello, Charles A ^c   Shannon, John M ^b   Westcott, Jay Y ^a   Zhang, Lening ^a   Mason, Robert J ^a,c  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Cyclooxygenase 2; Interleukin 1 ; Interleukin 1 ; Keratinocyte growth factor; Prostaglandin E2

Indexed keywords

CYCLOOXYGENASE 2; INDOMETACIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; KERATINOCYTE GROWTH FACTOR; NEUTRALIZING ANTIBODY; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; INTERLEUKIN 1;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL TYPE 2; LUNG FIBROBLAST; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE CULTURE CELL; ANIMAL; BIOSYNTHESIS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FIBROBLAST; LUNG ALVEOLUS; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CELL PROLIFERATION; COCULTURE TECHNIQUES; CYCLOOXYGENASE 2; DINOPROSTONE; FIBROBLAST GROWTH FACTOR 7; FIBROBLASTS; HUMANS; INTERLEUKIN-1; MALE; PULMONARY ALVEOLI; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33644839990     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00102.2005     Document Type: Article

References (52)

1. Aaronson SA, Bottaro DP, Miki T, Ron D, Finch PW, Fleming TP, Ahn J, Taylor WG, and Rubin JS. Keratinocyte growth factor. A fibroblast growth factor family member with unusual target cell specificity. Ann NY Acad Sci: 62-77, 1991.
2. Adamson IY, Young L, and Bowden DH. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol 130: 377-383, 1988.
3. Adamson IYR, Hedgecock C, and Bowden DH. Epithelial cell-fibroblast interactions in lung injury and repair. Am J Pathol 137: 385-392, 1990.
4. Adamson IYR, Young L, and King GM. Reciprocal epithelial: fibroblast interactions in the control of fetal and adult rat lung cells in culture. Exp Lung Res 17: 821-835, 1991.
5. Bitterman PB, Wewers MD, Rennard SI, Adelberg S, and Crystal RG. Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. J Clin Invest 77: 700-708, 1986.
6. 2 counteracts interleukin-1β-stimulated upregulation of platelet-derived growth factor α-receptor on rat pulmonary myofibroblasts. Am J Respir Cell Mol Biol 20: 433-440, 1999.
7. Deterding RR, Havill AM, Yano T, Middleton SC, Jacoby CR, Shannon JM, Simonet WS, and Mason RJ. Prevention of bleomycin-induced lung injury in rats by keratinocyte growth factor. Proc Assoc Am Physicians 109: 254-268, 1997.
8. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147, 1996.
9. Dinarello CA. Blocking IL-1 in systemic inflammation. J Exp Med 201: 1355-1359, 2005.
10. Dinarello CA. Interleukin-1β, interleukin-18, and the interleukin-1β converting enzyme. Ann NY Acad Sci 856: 1-11, 1998.
11. Dinarello CA. Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. Curr Opin Pharmacol 4: 378-385, 2004.
12. Dobbs LG, Geppert EF, Williams MC, Greenleaf RD, and Mason RJ. Metabolic properties and ultrastructure of alveolar type II cells isolated with elastase. Biochim Biophys Acta 618: 510-523, 1980.
13. Elias JA. Tumor necrosis factor interacts with interleukin-1 and interferons to inhibit fibroblast proliferation via fibroblast prostaglandin-dependent and -independent mechanisms. Am Rev Respir Dis 138: 652-658, 1988.
14. 2 synthesis by human lung fibroblasts. Am J Respir Cell Mol Biol 12: 358-365, 1995.
15. 2 on the activation of quiescent lung fibroblasts. Prostaglandins 33: 903-913, 1987.
16. 2 on transforming growth factor-β and insulin-induced collagen formation in lung fibroblasts. J Biol Chem 264: 16988-16991, 1989.
17. Fitzgerald AA, Leclercq SA, Yan A, Homik JE, and Dinarello CA. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum 52: 1794-1803, 2005.
18. Goldstein RH and Polgar P. The effect and interaction of bradykinin and prostaglandins on protein and collagen production by lung fibroblasts. J Biol Chem 257: 8630-8633, 1982.
19. Graham MF, Willey A, Adams J, Yager D, and Diegelmann RF. Interleukin 1β down-regulates collagen and augments collagenase expression in human intestinal smooth muscle cells. Gastroenterology 110: 344-350, 1996.
20. Han DS, Li F, Holt L, Connolly K, Hubert M, Miceli R, Okoye Z, Santiago G, Windle K, Wong E, and Sartor RB. Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats. Am J Physiol Gastrointest Liver Physiol 279: G1011-G1022, 2000.
21. Johnston CJ, Piedboeuf B, Rubin P, Williams JP, Baggs R, and Finkelstein JN. Early and persistent alterations in the expression of interleukin-1α, interleukin-1β and tumor necrosis factor α mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation. Radiat Res 145: 762-767, 1996.
22. Kaplanski G, Farnarier C, Kaplanski S, Porat R, Shapiro L, Bongrand P, and Dinarello CA. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood 84: 4242-4248, 1994.
23. Kawamoto M, Romberger DJ, Nakamura Y, Adachi Y, Tate L, Ertl RF, Spurzem JR, and Rennard SI. Modulation of fibroblast type I collagen and fibronectin production by bovine bronchial epithelial cells. Am J Respir Cell Mol Biol 12: 425-433, 1995.
24. Kay J and Calabrese L. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 43, Suppl 3: iii2-iii9, 2004.
25. Keerthisingam CB, Jenkins RG, Harrison NK, Hernandez-Rodriguez NA, Booth H, Laurent GJ, Hart SL, Foster ML, and McAnulty RJ. Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-β in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 158: 1411-1422, 2001.
26. Klien JH and Adamson IYR. Fibroblast inhibition and prostaglandin secretion by alveolar epithelial cells exposed to silica. Lab Invest 60: 808-813, 1989.
27. 2 inhibits fibroblast chemotaxis. Am J Physiol Lung Cell Mol Physiol 281: L1257-L1263, 2001.
28. Kolb M, Margetts PJ, Anthony DC, Pitossi F, and Gauldie J. Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 107: 1529-1536, 2001.
29. 2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent. Am J Respir Cell Mol Biol 27: 752-758, 2002.
30. 2 in human fibroblasts. J Biol Chem 267: 23451-23454, 1992.
31. 2 but not procollagen synthesis via a pertussis toxin-sensitive G-protein. Biochem J 307: 63-68, 1995.
32. 2. Am J Physiol Lung Cell Mol Physiol 284: L342-L349, 2003.
33. 2 synthesis by lung fibroblasts isolated from rats with bleomycin-induced lung fibrosis. Int J Exp Pathol 80: 41-49, 1999.
34. Pan LH, Ohtani H, Yamauchi K, and Nagura H. Co-expression of TNFα and IL-1β in human acute pulmonary fibrotic diseases: an immunohistochemical analysis. Pathol Int 46: 91-99, 1996.
35. Pan T, Mason RJ, Westcott JY, and Shannon JM. Rat alveolar type II cells inhibit lung fibroblast proliferation in vitro. Am J Respir Cell Mol Biol 25: 353-361, 2001.
36. Panos RJ, Rubin JS, Csaky KG, Aaronson SA, and Mason RJ. Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium. J Clin Invest 92: 969-977, 1993.
37. Pascual V, Allantaz F, Arce E, Punaro M, and Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 201: 1479-1486, 2005.
38. Piguet PF, Vesin C, Grau GE, and Thompson RC. Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine 5: 57-61, 1993.
39. Pollock AS, Turck J, and Lovett DH. The prodomain of interleukin 1α interacts with elements of the RNA processing apparatus and induces apoptosis in malignant cells. FASEB J 17: 203-213, 2003.
40. Pradelles P, Grassi J, and Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholinesterase. Methods Enzymol 187: 24-34, 1990.
41. 2 production and cyclooxygenase 2 activity in fibroblasts. J Invest Dermatol 109: 334-339, 1997.
42. Selman M, King TE, and Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134: 136-151, 2001.
43. Shannon JM, Emrie PA, Fisher JH, Kuroki Y, Jennings SD, and Mason RJ. Effect of a reconstituted basement membrane on expression of surfactant apoproteins in cultured adult rat alveolar type II cells. Am J Respir Cell Mol Biol 2: 183-192., 1990.
44. Shannon JM, Mason RJ, and Jennings SD. Functional differentiation of alveolar type II epithelial cells in vitro: effects of cell shape, cell-matrix interactions and cell-cell interactions. Biochim Biophys Acta 931: 143-156, 1987.
45. Song X, Voronov E, Dvorkin T, Fima E, Cagnano E, Benharroch D, Shendler Y, Bjorkdahl O, Segal S, Dinarello CA, and Apte RN. Differential effects of IL-1α and IL-1β on tumorigenicity patterns and invasiveness. J Immunol 171: 6448-6456, 2003.
46. Watanabe N and Kobayashi Y. Selective release of a processed form of interleukin 1α. Cytokine 6: 597-601, 1994.
47. Werman A, Werman-Venkert R, White R, Lee JK, Werman B, Krelin Y, Voronov E, Dinarello CA, and Apte RN. The precursor form of IL-1α is an intracrine proinflammatory activator of transcription. Proc Natl Acad Sci USA 101: 2434-2439, 2004.
48. Westcott JY, Johnston K, Batt RA, Wenzel SE, and Voelkel NF. Measurement of peptidoleukotrienes in biological fluids. J Appl Physiol 68: 2640-2648, 1990.
49. 2 and to express cyclooxygenase-2. J Clin Invest 95: 1861-1868, 1995.
50. Yano T, Deterding RR, Simonet WS, Shannon JM, and Mason RJ. Keratinocyte growth factor reduces lung damage due to acid instillation in rats. Am J Respir Cell Mol Biol 15: 433-442, 1996.
51. Yi ES, Williams ST, Lee H, Malicki DM, Chin EM, Yin S, Tarpley J, and Ulich TR. Keratinocyte growth factor ameliorates radiation- and bleomycin-induced lung injury and mortality. Am J Pathol 149: 1963-1970, 1996.
52. Young L and Adamson IY. Epithelial-fibroblast interactions in bleomycin-induced lung injury and repair. Environ Health Perspect 101: 56-61, 1993.